Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
ASCO GU 2022: Prostate roundup
Prof Eleni Efstathiou, Prof Axel Merseburger and Dr Neal Shore
ASCO GU 2022: Prostate roundup ( Prof Eleni Efstathiou, Prof Axel Merseburger and Dr Neal Shore )
20 Apr 2022
Recurrent non-invasive breast tumours may not always be related to the primary l...
Dr Tanjina Kader - University of Melbourne, Melbourne, Australia
Recurrent non-invasive breast tumours may not always be related to the primary lesion ( Dr Tanjina Kader - University of Melbourne, Melbourne, Australia )
19 Apr 2022
Safety and efficacy of olaparib plus metronomic cyclophosphamide and metformin i...
Prof Benoit You - Hospices Civils de Lyon, Lyon, France
Safety and efficacy of olaparib plus metronomic cyclophosphamide and metformin in advanced/metastatic endometrial cancer ( Prof Benoit You - Hospices Civils de Lyon, Lyon, France )
14 Apr 2022
Novel bispecific checkpoint inhibitor MEDI5752 shows promise for advanced solid ...
Dr Ben Tran - Peter MacCallum Cancer Centre, Melbourne, Australia
Novel bispecific checkpoint inhibitor MEDI5752 shows promise for advanced solid tumours ( Dr Ben Tran - Peter MacCallum Cancer Centre, Melbourne, Australia )
14 Apr 2022
The adverse events atlas, towards a strategy to predict synergistic adverse even...
Prof Bart Westerman - Amsterdam UMC, Amsterdam, Netherlands
The adverse events atlas, towards a strategy to predict synergistic adverse events of combination therapies ( Prof Bart Westerman - Amsterdam UMC, Amsterdam, Netherlands )
13 Apr 2022
Safety and efficacy of the oral ATR inhibitor elimusertib in advanced solid tumo...
Dr Timothy Yap - MD Anderson Cancer Center, Houston, USA
Safety and efficacy of the oral ATR inhibitor elimusertib in advanced solid tumours with DNA damage response defects ( Dr Timothy Yap - MD Anderson Cancer Center, Houston, USA )
13 Apr 2022
PETRA: Next generation PARP1-selective inhibitor AZD5305 in patients with BRCA1/...
Dr Timothy Yap - MD Anderson Cancer Center, Houston, USA
PETRA: Next generation PARP1-selective inhibitor AZD5305 in patients with BRCA1/2, PALB2 or RAD51C/D mutations ( Dr Timothy Yap - MD Anderson Cancer Center, Houston, USA )
13 Apr 2022
Novel COVID-19 vaccine for B-cell deficient patients
Prof Juliane Walz - University Hospital Tübingen, Tübingen, Germany
Novel COVID-19 vaccine for B-cell deficient patients ( Prof Juliane Walz - University Hospital Tübingen, Tübingen, Germany )
12 Apr 2022
Paediatric cancer patients in LMICS faced significantly higher mortality risk du...
Dr Muhammed Elhadi - University of Tripoli, Tripoli, Libya
Paediatric cancer patients in LMICS faced significantly higher mortality risk during the COVID-19 pandemic ( Dr Muhammed Elhadi - University of Tripoli, Tripoli, Libya )
11 Apr 2022
FAP-targeted PET imaging in cancer patients
Prof Jérémie Calais - UCLA, Los Angeles, USA
FAP-targeted PET imaging in cancer patients ( Prof Jérémie Calais - UCLA, Los Angeles, USA )
1 Apr 2022
FAP-targeted molecular radiotherapy in cancer patients
Prof Jérémie Calais - UCLA, Los Angeles, USA
FAP-targeted molecular radiotherapy in cancer patients ( Prof Jérémie Calais - UCLA, Los Angeles, USA )
1 Apr 2022
Immune gene signatures for predicting response to neoadjuvant chemoimmunotherapy...
Dr Marta Casarrubios - Hospital Universitario Puerta de Hierro-Majadahonda, Madr...
Immune gene signatures for predicting response to neoadjuvant chemoimmunotherapy in NSCLC ( Dr Marta Casarrubios - Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain )
31 Mar 2022